Short answer · Medically reviewed summary · Last updated: 2026-04-07
Schwartz-Jampel syndrome is classified under the ICD-10 code Q78.8 (Other specified osteochondrodysplasias) and the ICD-9 code 756.59 (Other specified disorders of bone and cartilage). These codes facilitate accurate medical billing and documentation for this rare genetic disorder characterized by myotonia and skeletal abnormalities. What is the clinical classification of Schwartz-Jampel syndrome? Schwartz-Jampel syndrome (SJS) is a rare autosomal recessive disorder that is clinically defined by the triad of permanent myotonia (muscle stiffness), skeletal dysplasia (bone abnormalities), and distinctive facial features.
Schwartz-Jampel syndrome is classified under the ICD-10 code Q78.8 (Other specified osteochondrodysplasias) and the ICD-9 code 756.59 (Other specified disorders of bone and cartilage). These codes facilitate accurate medical billing and documentation for this rare genetic disorder characterized by myotonia and skeletal abnormalities.
Schwartz-Jampel syndrome (SJS) is a rare autosomal recessive disorder that is clinically defined by the triad of permanent myotonia (muscle stiffness), skeletal dysplasia (bone abnormalities), and distinctive facial features. Because it is a rare condition, accurate coding is essential for medical records. While ICD-10 code Q78.8 is the standard for Schwartz-Jampel syndrome, clinicians may also use supplemental codes to describe specific manifestations, such as blepharophimosis or joint contractures, to ensure comprehensive patient care.
Living with Schwartz-Jampel syndrome presents unique physical and emotional challenges. Patients often experience progressive joint stiffness and muscle hypertrophy, which can impact mobility and fine motor skills. Our community at DiseaseMaps.org, which currently includes 16 individuals living with Schwartz-Jampel syndrome, highlights the importance of multidisciplinary care. Managing the chronic nature of this condition requires not only orthopedic and neurological intervention but also psychological support to navigate the isolation that can accompany a rare diagnosis.
Yes, Schwartz-Jampel syndrome is inherited in an autosomal recessive pattern. This means that both parents must carry a mutation in the HSPG2 gene, which encodes the protein perlecan. When both parents are carriers, there is a 25% chance with each pregnancy of having a child affected by the syndrome. Genetic counseling is strongly recommended for families affected by Schwartz-Jampel syndrome to understand the risks and explore reproductive options.
The clinical presentation of Schwartz-Jampel syndrome can vary, but most patients exhibit a consistent set of physical characteristics that aid in diagnosis:
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider.